724 research outputs found
Π€Π»Π΅ΠΊΡΠΈΠ±ΠΈΠ»Π½Π°ΡΠ° Π΅Π½Π΄ΠΎΡΠΊΠΎΠΏΠΈΡ ΠΏΡΠΈ Π·Π°Π±ΠΎΠ»ΡΠ²Π°Π½ΠΈΡ Π½Π° Π³ΠΎΡΠ½ΠΈΡΠ΅ Π΄ΠΈΡ Π°ΡΠ΅Π»Π½ΠΈ ΠΏΡΡΠΈΡΠ° β Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠ½ΠΈ ΡΠ΅Π·ΡΠ»ΡΠ°ΡΠΈ ΠΈ ΠΏΠΎΠ»Π·ΠΈ
Π¦Π΅Π»ΠΈΡΠ΅ Π½Π° ΡΠ°Π·ΠΈ ΡΡΠ°ΡΠΈΡ ΡΠ° Π΄Π° ΡΠ΅ ΠΏΡΠΎΡΡΠ°Ρ ΠΈ ΠΈΠ·Π»ΠΎΠΆΠ°Ρ Π²ΡΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΠΈΡΠ΅ ΠΈ ΠΏΡΠ΅Π΄ΠΈΠΌΡΡΠ²Π°ΡΠ° Π½Π° ΡΠ»Π΅ΠΊΡΠΈΠ±ΠΈΠ»Π½Π°ΡΠ° Π΅Π½Π΄ΠΎΡΠΊΠΎΠΏΠΈΡ Π½Π° Π³ΠΎΡΠ½ΠΈΡΠ΅ Π΄ΠΈΡ
Π°ΡΠ΅Π»Π½ΠΈ ΠΏΡΡΠΈΡΠ° Π² ΠΎΡΠΎΡΠΈΠ½ΠΎΠ»Π°ΡΠΈΠ½Π³ΠΎΠ»ΠΎΠ³ΠΈΡΠ½Π°ΡΠ° ΠΏΡΠ°ΠΊΡΠΈΠΊΠ°.ΠΡΡΡ
Ρ 191 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΈ Ρ ΡΠ°Π·Π»ΠΈΡΠ½ΠΈ Π·Π°Π±ΠΎΠ»ΡΠ²Π°Π½ΠΈΡ Π½Π° Π³ΠΎΡΠ½ΠΈΡΠ΅ Π΄ΠΈΡ
Π°ΡΠ΅Π»Π½ΠΈ ΠΏΡΡΠΈΡΠ° Π·Π° ΠΏΠ΅ΡΠΈΠΎΠ΄Π° ΡΠ½ΠΈ 2008 Π΄ΠΎ ΡΠ½ΠΈ 2011 Π³., Π² Π£ΠΠ-ΠΊΠ»ΠΈΠ½ΠΈΠΊΠ° Π½Π° Π£ΠΠΠΠ βΠ‘Π². ΠΠ΅ΠΎΡΠ³ΠΈβ β ΠΠ»ΠΎΠ²Π΄ΠΈΠ² ΠΈΠ·Π²ΡΡΡΠΈΡ
ΠΌΠ΅ Π² Π°ΠΌΠ±ΡΠ»Π°ΡΠΎΡΠ΅Π½ ΠΏΠΎΡΡΠ΄ΡΠΊ ΠΈΠ»ΠΈ ΠΏΡΠΈ Π»Π΅Π³Π»ΠΎΡΠΎ Π½Π° Π±ΠΎΠ»Π½ΠΈΡ ΡΠΈΠ±ΡΠΎΠ½Π°Π·ΠΎ-Π΅ΠΏΠΈΡΠ°ΡΠΈΠ½Π³ΠΎΠ»Π°ΡΠΈΠ½Π³ΠΎΡΠΊΠΎΠΏΠΈΠΈ. ΠΠ·ΡΠ»Π΅Π΄Π²Π°Π½Π΅ΡΠΎ ΠΈΠ·Π²ΡΡΡΠ²Π°Ρ
ΠΌΠ΅ ΠΏΠΎΠ΄ ΠΌΠ΅ΡΡΠ½Π° Π°Π½Π΅ΡΡΠ΅Π·ΠΈΡ, Ρ ΡΡΠ°Π½ΡΠ½Π°Π·Π°Π»Π΅Π½ Π΄ΠΎΡΡΡΠΏ ΠΊΠ°ΡΠΎ ΠΈΠ·ΠΏΠΎΠ»Π·Π²Π°Ρ
ΠΌΠ΅ Π½Π°Π·Π°Π»Π½ΠΈ Π΄Π΅ΠΊΠΎΠ½Π³Π΅ΡΡΠ°Π½ΡΠΈ. ΠΠΎΠΊΠ°Π·Π°Π½ΠΈΡ Π·Π° Π΅Π½Π΄ΠΎΡΠΊΠΎΠΏΠΈΡΡΠ° Π½Π° Π³ΠΎΡΠ½ΠΈΡ Π΄ΠΈΡ
Π°ΡΠ΅Π»Π΅Π½ ΠΏΡΡ Π±ΡΡ
Π° β Π΄ΠΈΡΡΠΎΠ½ΠΈΡ, Π΄ΠΈΡΡΠ°Π³ΠΈΡ ΠΈ Π·Π°ΡΡΡΠ΄Π½Π΅Π½ΠΎ Π½ΠΎΡΠ½ΠΎ Π΄ΠΈΡΠ°Π½Π΅ ΠΏΡΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΈ, Π½Π° ΠΊΠΎΠΈΡΠΎ ΠΊΠ»Π°ΡΠΈΡΠ΅ΡΠΊΠ°ΡΠ° ΠΎΠ³Π»Π΅Π΄Π°Π»Π½Π° Π΅ΠΏΠΈΡΠ°ΡΠΈΠ½Π³ΠΎ ΠΈ Π»Π°ΡΠΈΠ½Π³ΠΎΡΠΊΠΎΠΏΠΈΡ Π½Π΅ Π΄Π°Π²Π°Ρ
Π° ΠΈΠ·ΡΠ΅ΡΠΏΠ°ΡΠ΅Π»Π½Π° ΠΈΠ½ΡΠΎΡΠΌΠ°ΡΠΈΡ Π·Π° ΠΏΠΎΡΡΠ°Π²ΡΠ½Π΅ΡΠΎ Π½Π° Π΄ΠΈΠ°Π³Π½ΠΎΠ·Π°ΡΠ°, ΠΊΠ°ΠΊΡΠΎ ΠΈ ΠΏΡΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΈ Ρ ΡΠ΅ΠΆΠΊΠΈ ΠΏΡΠΈΠ΄ΡΡΠΆΠ°Π²Π°ΡΠΈ Π·Π°Π±ΠΎΠ»ΡΠ²Π°Π½ΠΈΡ, ΠΏΡΠΈ ΠΊΠΎΠΈΡΠΎ ΠΈΠ·Π²ΡΡΡΠ²Π°Π½Π΅ΡΠΎ Π½Π° Π΄ΠΈΡΠ΅ΠΊΡΠ½Π° Π»Π°ΡΠΈΠ½Π³ΠΎΡΠΊΠΎΠΏΠΈΡ ΠΏΠΎΠ΄ ΠΎΠ±ΡΠ° Π°Π½Π΅ΡΡΠ΅Π·ΠΈΡ Π±Π΅ΡΠ΅ ΠΏΡΠΎΡΠΈΠ²ΠΎΠΏΠΎΠΊΠ°Π·Π°Π½ΠΎ Π·Π°ΡΠ°Π΄ΠΈ ΡΠ΅ΠΆΠΊΠΈ ΠΏΡΠΈΠ΄ΡΡΠΆΠ°Π²Π°ΡΠΈ Π·Π°Π±ΠΎΠ»ΡΠ²Π°Π½ΠΈΡ ΠΈ ΠΏΠΎΠ²ΠΈΡΠ΅Π½ ΡΠΈΡΠΊ ΠΎΡ ΠΆΠΈΠ²ΠΎΡΠΎΠ·Π°ΡΡΡΠ°ΡΠ°Π²Π°ΡΠΈ ΠΈΠ½ΡΠΈΠ΄Π΅Π½ΡΠΈ ΠΏΠΎ Π²ΡΠ΅ΠΌΠ΅ Π½Π° Π°Π½Π΅ΡΡΠ΅Π·ΠΈΡΡΠ°. Π Π°Π±ΠΎΡΠ΅Ρ
ΠΌΠ΅ Ρ ΡΠΈΠ±ΡΠΎΠ±ΡΠΎΠ½Ρ
ΠΎΡΠΊΠΎΠΏ Olympus Ρ Π²ΡΠ½ΡΠ΅Π½ Π΄ΠΈΠ°ΠΌΠ΅ΡΡΡ 2,2 ΠΌΠΌ ΠΈ ΡΠ°Π±ΠΎΡΠ΅Π½ ΠΊΠ°Π½Π°Π» 1,2 ΠΌΠΌ ΡΠ½Π°Π±Π΄Π΅Π½ Ρ ΡΠΈΠ±ΡΠΎΡΠΈΠΏΠΊΠ°, ΠΊΠΎΠΉΡΠΎ ΠΈΠ·ΠΏΠΎΠ»Π·Π²Π°Ρ
ΠΌΠ΅ Π·Π° ΠΎΠ³Π»Π΅Π΄ Π½Π° Π΄Π΅ΡΠ° Π²ΠΊΠ»ΡΡΠΈΡΠ΅Π»Π½ΠΎ ΠΈ Π½ΠΎΠ²ΠΎΡΠΎΠ΄Π΅Π½ΠΈ. ΠΠ° Π²ΡΠ·ΡΠ°ΡΡΠ½ΠΈ ΠΈΠ·ΠΏΠΎΠ»Π·ΡΠ²Π°Ρ
ΠΌΠ΅ ΡΠΈΠ±ΡΠΎΠ±ΡΠΎΠ½Ρ
ΠΎΡΠΊΠΎΠΏ Karl Storz Ρ5,2 ΠΌΠΌ Ρ ΡΠ°Π±ΠΎΡΠ΅Π½ ΠΊΠ°Π½Π°Π» 3,2 ΠΌΠΌ. Π€ΠΈΠ±ΡΠΎΠ΅Π½Π΄ΠΎΡΠΊΠΎΠΏΠΈΡΠ΅ Π°Π΄Π°ΠΏΡΠΈΡΠ°Ρ
ΠΌΠ΅ ΠΊΡΠΌ Π΅Π½Π΄ΠΎΡΠΊΠΎΠΏΡΠΊΠ° Π²ΠΈΠ΄Π΅ΠΎΠΊΠ°ΠΌΠ΅ΡΠ° Olympus ΡΠ²ΡΡΠ·Π°Π½Π° Ρ Π²ΠΈΠ΄Π΅ΠΎΠΌΠΎΠ½ΠΈΡΠΎΡ ΠΈ Π·Π°ΠΏΠΈΡΠ²Π°ΡΠΎ DVD Π·Π° ΡΠΎΡΠΎΠ΄ΠΎΠΊΡΠΌΠ΅Π½ΡΠ°ΡΠΈΡ. ΠΡΠ΅Π· ΠΏΠΎΡΠ»Π΅Π΄Π½Π°ΡΠ° Π³ΠΎΠ΄ΠΈΠ½Π° ΠΎΡ Π½Π°ΡΠ΅ΡΠΎ ΠΏΡΠΎΡΡΠ²Π°Π½Π΅ ΠΈΠ·ΡΠ»Π΅Π΄Π²Π°Π½ΠΈΡΡΠ° ΠΈΠ·Π²ΡΡΡΠ²Π°Ρ
ΠΌΠ΅ ΡΡΡ XYON ΡΠ»Π΅ΠΊΡΠΈΠ±ΠΈΠ»Π΅Π½ Π½Π°Π·ΠΎΡΠ°ΡΠΈΠ½Π³ΠΎΠ»Π°ΡΠΈΠ½Π³ΠΎΡΠΊΠΎΠΏ Ρ Π²ΠΈΠ΄Π΅ΠΎΠΌΠΎΠ½ΠΈΡΠΎΡ.Π Π΅Π·ΡΠ»ΡΠ°ΡΠΈ: ΠΠ° 191 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΈ , ΠΎΡ ΠΊΠΎΠΈΡΠΎ 151 ΠΌΡΠΆΠ΅ (80,29%) ΠΈ 40 ΠΆΠ΅Π½ΠΈ (20.8%), Π½Π° ΡΡΠ΅Π΄Π½Π° Π²ΡΠ·ΡΠ°ΡΡ 48.4 Π³ΠΎΠ΄ΠΈΠ½ΠΈ ΠΈΠ·Π²ΡΡΡΠ²Π°Ρ
ΠΌΠ΅ ΡΠΈΠ±ΡΠΎΠ΅Π½Π΄ΠΎΡΠΊΠΎΠΏΠΈΠΈ Π½Π° Π³ΠΎΡΠ½ΠΈΡΠ΅ Π΄ΠΈΡ
Π°ΡΠ΅Π»Π½ΠΈ ΠΏΡΡΠΈΡΠ°. ΠΠ°ΠΉ-ΡΠ΅ΡΡΠΈΡΠ΅ Π·Π°Π±ΠΎΠ»ΡΠ²Π°Π½ΠΈΡ, ΠΊΠΎΠΈΡΠΎ ΠΎΡΠΊΡΠΈΡ
ΠΌΠ΅ ΠΏΡΠΈ ΡΠ΅ΡΠΈΡΡΠ° ΠΎΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΈ Π±ΡΡ
Π° ΡΠ»Π΅Π΄Π½ΠΈΡΠ΅: Π±Π΅Π½ΠΈΠ³Π½Π΅Π½ΠΈ Π°Π±Π½ΠΎΡΠΌΠ°Π»ΠΈΡΠ΅ΡΠΈ Π½Π° Π»Π°ΡΠΈΠ½ΠΊΡΠ° 51 (26,7%), ΠΊΠ°ΡΡΠΈΠ½ΠΎΠΌΠΈ Π½Π° Π»Π°ΡΠΈΠ½ΠΊΡΠ° 24 (12.3%), ΠΊΠ°ΡΡΠΈΠ½ΠΎΠΌΠΈ Π½Π° Ρ
ΠΈΠΏΠΎΡΠ°ΡΠΈΠ½ΠΊΡΠ° 18 (9,2%), ΠΊΠ°ΡΡΠΈΠ½ΠΎΠΌΠΈ Π½Π° Π΅ΠΏΠΈΡΠ°ΡΠΈΠ½ΠΊΡΠ° 14 (7,2%), ΠΏΠ°ΡΠ΅Π·ΠΈ Π½Π° Π³Π»Π°ΡΠ½ΠΈΡΠ΅ Π²ΡΡΠ·ΠΊΠΈ 26 (13,4%), Π΅Π΄Π΅ΠΌ Π½Π° Π»Π°ΡΠΈΠ½ΠΊΡΠ° 8 (4,1%), Π½Π°Π·Π°Π»Π½Π° ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡ 28 (14,4%) Π²ΡΠΎΠ΄Π΅Π½ΠΈ Π°Π½ΠΎΠΌΠ°Π»ΠΈΠΈ 5 (2,5%), ΡΠΌΡΡΠ΅Π½ΠΈΡ Π² Π°ΠΊΡΠ° Π½Π° Π³ΡΠ»ΡΠ°Π½Π΅ΡΠΎ ΡΠ»Π΅Π΄ ΡΠ°ΡΡΠΈΡΠ½ΠΈ Ρ
ΠΎΡΠΈΠ·ΠΎΠ½ΡΠ°Π»Π½ΠΈ ΡΠ΅Π·Π΅ΠΊΡΠΈΠΈ Π½Π° Π»Π°ΡΠΈΠ½ΠΊΡΠ° ΠΏΠΎ ΠΏΠΎΠ²ΠΎΠ΄ ΠΊΠ°ΡΡΠΈΠ½ΠΎΠΌ 8 (4,1%), ΡΡΠΆΠ΄ΠΈ ΡΠ΅Π»Π° Π² Π½ΠΎΡΠ° Π½Π°Π·ΠΎ,Ρ
ΠΈΠΏΠΎΡΠ°ΡΠΈΠ½ΠΊΡΠ° ΠΈ Ρ
ΡΠ°Π½ΠΎΠΏΡΠΎΠ²ΠΎΠ΄Π° 6 (3,09%).ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅: Π€Π»Π΅ΠΊΡΠΈΠ±ΠΈΠ»Π½Π°ΡΠ° Π΅Π½Π΄ΠΎΡΠΊΠΎΠΏΠΈΡ Π½Π° Π³ΠΎΡΠ½ΠΈΡΠ΅ Π΄ΠΈΡ
Π°ΡΠ΅Π»Π½ΠΈ ΠΏΡΡΠΈΡΠ° Π΅ ΠΈΠ·ΠΊΠ»ΡΡΠΈΡΠ΅Π»Π½ΠΎ Π΅ΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎ ΠΈΠ½ΡΡΡΡΠΌΠ΅Π½ΡΠ°Π»Π½ΠΎ ΠΈΠ·ΡΠ»Π΅Π΄Π²Π°Π½Π΅ ΠΏΡΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΈ Ρ ΡΠ°Π·Π»ΠΈΡΠ½Π° ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡ Π½Π° Π³ΠΎΡΠ½ΠΈΡΠ΅ Π΄ΠΈΡ
Π°ΡΠ΅Π»Π½ΠΈ ΠΏΡΡΠΈΡΠ°. ΠΡΠΎΡΠ΅Π΄ΡΡΠ°ΡΠ° Π΅ Π»Π΅ΡΠ½ΠΎ ΠΈΠ·ΠΏΡΠ»Π½ΠΈΠΌΠ° ΠΏΠΎΠ΄ Π»ΠΎΠΊΠ°Π»Π½Π° Π°Π½Π΅ΡΡΠ΅Π·ΠΈΡ Π² Π°ΠΌΠ±ΡΠ»Π°ΡΠΎΡΠ½ΠΈ ΡΡΠ»ΠΎΠ²ΠΈΡ, ΠΊΠ°ΠΊΡΠΎ ΠΈ ΠΏΡΠΈ Π»Π΅Π³Π»ΠΎΡΠΎ Π½Π° Π±ΠΎΠ»Π½ΠΈΡ. ΠΡΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΠΈΡΠ΅ Π·Π° Π²Π·ΠΈΠΌΠ°Π½Π΅ Π½Π° Π±ΠΈΠΎΠΏΡΠΈΠΈ ΠΏΠΎΠ΄ Π»ΠΎΠΊΠ°Π»Π½Π° Π°Π½Π΅ΡΡΠ΅Π·ΠΈΡ ΠΏΠΎ Π²ΡΠ΅ΠΌΠ΅ Π½Π° Π΅Π½Π΄ΠΎΡΠΊΠΎΠΏΡΠΊΠΈΡ ΠΎΠ³Π»Π΅Π΄ Ρ ΠΏΡΠ°Π²ΠΈ ΡΠ΅Π½Π΅Π½ ΠΏΡΠΈΠ΄Π°ΡΡΠΊ ΠΊΠ°ΠΊΡΠΎ Π² ΠΎΠ±ΡΠ°Π·Π½ΠΎΡΠΎ ΠΈΠ·ΡΠ»Π΅Π΄Π²Π°Π½Π΅ Π½Π° Π³ΠΎΡΠ½ΠΈΡ Π΄ΠΈΡ
Π°ΡΠ΅Π»Π΅Π½ ΠΏΡΡ, ΡΠ°ΠΊΠ° ΠΈ Π² Ρ
ΠΈΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ½Π°ΡΠ° Π²Π΅ΡΠΈΡΠΈΠΊΠ°ΡΠΈΡ Π½Π° ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ½ΠΈ ΠΏΡΠΎΡΠ΅ΡΠΈ Π½Π° Π³ΠΎΡΠ½ΠΈΡΡ Π΄ΠΈΡ
Π°ΡΠ΅Π»Π΅Π½ ΠΏΡΡ. Π’Π΅Ρ
Π½ΠΎΠ»ΠΎΠ³ΠΈΡΠ½ΠΈΡΡ Π½Π°ΠΏΡΠ΅Π΄ΡΠΊ Π² ΠΎΠ±Π»Π°ΡΡΡΠ° Π΄Π°Π²Π° Π²ΡΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡ Π·Π° ΡΡΠ·Π΄Π°Π²Π°Π½Π΅ Π½Π° Π΅Π½Π΄ΠΎΡΠΊΠΎΠΏΡΠΊΠ° Π°ΠΏΠ°ΡΠ°ΡΡΡΠ°, ΠΏΡΠΈΠ»ΠΎΠΆΠΈΠΌΠ° Π·Π° ΠΈΠ·ΡΠ»Π΅Π΄Π²Π°Π½ΠΈΡ Π΄ΠΎΡΠΈ ΠΏΡΠΈ Π½ΠΎΠ²ΠΎΡΠΎΠ΄Π΅Π½ΠΈ
Jacobi Identity for Vertex Algebras in Higher Dimensions
Vertex algebras in higher dimensions provide an algebraic framework for
investigating axiomatic quantum field theory with global conformal invariance.
We develop further the theory of such vertex algebras by introducing formal
calculus techniques and investigating the notion of polylocal fields. We derive
a Jacobi identity which together with the vacuum axiom can be taken as an
equivalent definition of vertex algebra.Comment: 35 pages, references adde
CELL DEATH DIFFERENTIATION IN BLACK HEADED RAMS SPERMATOZOA, USING FLUORESCENT LABELED ANNEXIN V
Double staining kit of Annexin V Cy3.18/6-CFDA was used to investigate the changes in phospholipide asymmetry after treating sperm cells with dexamethasone. The % of spermatozoa with registered translocation of PS in treated with dexamethazone groups at the 10-th min and in control no treated varied from 2.74%Β±0.65 to 2.30%Β±0.89. After the 5 hour of incubation these % increased to 39.83Β±3.33 for the treated group and 23.44Β±1.12 for the control. It was concluded that Annexin V binding assay is more sensitive in the detection of deterioration in membrane function than other conventional methods such as motility analysis and supravital techniques
Opportunistic screening for hypertension in the general population in Bulgaria: international society of hypertension may measurement month campaign
Cardiovascular diseases are not only the leading causes of mortality in Bulgaria but also the mortality rate is twice as high as the European Union average, so screening programmes identifying subjects with elevated blood pressure (BP) are of utmost importance. May Measurement Month (MMM) is an annual global initiative of the International Society of hypertension that began in 2017 aimed at raising awareness of high BP. Bulgaria joined the 3rd campaign of MMM in 2019 and an overview of the results of Bulgarian participation are presented in this paper. Hypertension was defined as systolic BP β₯ 140 mm Hg and diastolic BP β₯ 90 mm Hg or treatment for hypertension, statistical analysis followed the standard MMM protocol. In Bulgaria, 150 screening points were set up in primary and secondary care facilities, in pharmacies, and outdoor spaces across 21 administrative districts. Out of 3678 individuals screened, 2587 participants (70.3%) had hypertension. Of 2896 participants with hypertension, 35.6% had controlled BP. Out of 1760 participants not on antihypertensive medication, 669 (38%) had elevated BP. In the case of treated individuals (n = 1918), 997 (52%) had uncontrolled hypertension. In the untreated cohort, every 4th subject had elevated BP, whilst among patients on antihypertensive medication, every second had uncontrolled BP, the worst results in terms of diagnosis and treatment are observed in men. By identifying almost two-third of the whole screened cohort with the possibility of newly diagnosed or uncontrolled hypertension, our results confirm the importance of BP screening campaigns
The 2D/3D Best-Fit Problem
In computer systems, the best-fit problem can be described as a search for the best transformation matrix to transform input mea- sured points from their coordinate system into a CAD model coordinate system using a criteria function for optimization. For example, if the criterion is Mini- mum Sum of Deviations, we search for a transformation matrix M that minimizes the sum of all distances from an matrix-transformed measure points to a CAD model
Oms1 associates with cytochrome c oxidase assembly intermediates to stabilize newly synthesized Cox1.
The mitochondrial cytochromecoxidase assembles in the inner membrane from subunits of dual genetic origin. The assembly process of the enzyme is initiated by membrane insertion of the mitochondria-encoded Cox1 subunit. During complex maturation, transient assembly intermediates, consisting of structural subunits and specialized chaperone-like assembly factors, are formed. In addition, cofactors such as heme and copper have to be inserted into the nascent complex. To regulate the assembly process, the availability of Cox1 is under control of a regulatory feedback cycle, in which translation of the COX1 mRNA is stalled when assembly intermediates of Cox1 accumulate through inactivation of the translational activator Mss51. Here we have isolated a cytochromecoxidase assembly intermediate in preparatory scale fromcoa1Ξmutant cells using Mss51 as a bait. We demonstrate that at this stage of assembly the complex has not yet incorporated the heme a cofactors. Using quantitative mass spectrometry, we defined the protein composition of the assembly intermediate and unexpectedly identified the putative methyltransferase Oms1 as a constituent. Our analyses show that Oms1 participates in cytochromecoxidase assembly by stabilizing newly synthesized Cox1
- β¦